APOBEC3B and Miyoshi myopathy: The high hazard ratio and predictive performance of APOBEC3B expression for adverse PFS and OS which appears to be independent from that of APOBEC-induced mutational signatures, likely reflects APOBEC3B’s additional involvement in MM pathogenesis through immune editing, viral and retroelement restriction, DNA demethylation, and tissue homeostasis [13].